INI-CET MDS study materials
INI-CET MDS study resources

Implant timing in a smoker with poorly controlled diabetes and active periodontitis

INI-CET MDS · Put your knowledge to work in context.

All case studies

Implant timing in a smoker with poorly controlled diabetes and active periodontitis

A 58-year-old man requests replacement of the lower left first molar, lost 4 months ago. He smokes 15 cigarettes a day and has type 2 diabetes treated with metformin; his latest HbA1c is 8.4%. He has no pain but generalised bleeding on probing, a plaque score of 45%, and 5-6 mm pockets on the distal of the second molar and the mesial of the second premolar; both adjacent teeth respond normally to pulp testing. Cone-beam CT shows a ridge 4.5 mm wide at the crest, 8 mm of bone above the inferior alveolar canal, and a 2 mm buccal concavity. There is no residual root and the soft tissue has healed flat. He asks for an implant 'as soon as possible' and will not consider a removable prosthesis.

1. Do you place the implant at this visit? Justify your sequencing.

Read the worked answer

No. Three uncontrolled variables would be loaded onto the implant at once: hyperglycaemia, smoking, and untreated periodontitis.

Diabetes: HbA1c of 8.4% is above the usual threshold for elective implant surgery. Hyperglycaemia impairs neutrophil function, collagen synthesis and microvascular healing, and is associated with higher failure and peri-implantitis rates. I would ask his physician to optimise control and re-test, aiming for HbA1c below about 7% (accepting up to 7.5-8% with caution and informed consent).

Smoking: 15 cigarettes daily roughly doubles implant failure and marginal bone loss risk, and compounds the diabetes effect. Documented cessation for at least 4 weeks before surgery and through healing is the target; nicotine replacement is acceptable.

Periodontitis: 5-6 mm pockets with 45% plaque and generalised bleeding mean an untreated infective burden adjacent to the planned site. A patient with treated periodontitis and good maintenance can be implanted; one with active disease should not.

Sequence: oral hygiene instruction and full-mouth debridement, physician referral, smoking cessation counselling, then reassessment at 6-8 weeks. Only when plaque and bleeding scores are low and pockets are closed or stabilised do we plan surgery. I would also check space: the adjacent teeth may have drifted, so the surgical plan must match the planned crown.

2. Given a 4.5 mm ridge width, a 2 mm buccal concavity and 8 mm of bone above the canal, what surgical options exist and which do you prefer?

Read the worked answer

A 4.5 mm crest is too narrow for a standard 4 mm implant with the 1.5-2 mm of buccal and lingual bone needed for long-term stability, and the buccal concavity makes a narrow implant prone to dehiscence.

Option 1 - staged ridge augmentation: particulate graft with a membrane or a block graft, 6-9 months of healing, then a 4 mm implant. Most predictable biologically, but two surgeries and a longer timeline.

Option 2 - simultaneous grafting with a narrow implant: place a 3.3-3.5 mm implant slightly lingualised with a simultaneous contour graft and resorbable membrane, accepting higher risk of buccal recession and that a buccal defect is harder to correct later.

Option 3 - short implant: with 8 mm above the canal, a 6 mm implant leaves about 2 mm of safety. This avoids nerve lateralisation, which carries a real risk of persistent neurosensory deficit and is not justified when 8 mm of bone is available.

My preference: option 1 if the patient accepts the timeline; option 2 only if the buccal plate can be fully contained and he accepts the risk of a second procedure. I would not choose nerve lateralisation here. Whichever is chosen, the implant should be prosthetically driven with a surgical guide, and the final decision confirmed on CBCT cross-sections.

3. What targets would you set before surgery, and how do they change your prognosis and follow-up?

Read the worked answer

Targets before surgery:

  • HbA1c at or below 7% (minimum acceptable 7.5-8% with documented consent), with stable fasting glucose.
  • Complete smoking cessation for at least 4 weeks preoperatively and through osseointegration; the ideal is permanent cessation.
  • Full-mouth plaque score below 20% and bleeding on probing below 15-20%, with the 5-6 mm pockets closed or surgically treated, and a signed commitment to 3-monthly maintenance.

Effect on prognosis: each factor is independent, and together they move this from a routine case to a guarded one. Smoking and poorly controlled diabetes increase early failure, delayed healing, and - more importantly for a 58-year-old - late peri-implantitis and marginal bone loss. A narrow implant placed with simultaneous grafting adds a further risk of mucosal recession and thread exposure. Realistic expectations should be documented: a functioning implant with annual radiographic review is achievable, but the failure and complication rate is materially higher than in a healthy non-smoker.

Follow-up: review at 1 and 2 weeks for soft tissue, then at 3 months before loading, then annually with probing depths, bleeding scores, periapical radiograph and occlusal check. A HbA1c review each year and repeated cessation advice are part of the implant maintenance plan, not an optional extra.